• Home
  • Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma.

Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma.

Author List
Khan AB, English CW, Chen WC, Athukuri P, Bayley JC, Brandt VL, Shetty A, Hadley CC, Choudhury A, Lu HC, Harmanci AO, Harmanci AS, Magill ST, Raleigh DR, Klisch TJ, Patel AJ
Publication
Acta neuropathologica
Publication ID (Profile URL)
https://researcherprofiles.org/profile/366107955
Publication Year
2023
PubMed ID
36729132
Publication Title
Khan AB, English CW, Chen WC, Athukuri P, Bayley JC, Brandt VL, Shetty A, Hadley CC, Choudhury A, Lu HC, Harmanci AO, Harmanci AS, Magill ST, Raleigh DR, Klisch TJ, Patel AJ. Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma. Acta Neuropathol. 2023 04; 145(4):501-503.